About this trial
The purpose of this sequential exploratory mixed-methods study is to examine the relationship between perimenopausal symptom severity and occupational performance, occupational balance, and role participation in women aged 40-55. A secondary purpose is to explore the lived experience of occupational disruption during perimenopause through qualitative interviews.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women aged 40-55
Self-reported perimenopausal symptoms
Currently employed (paid or unpaid) or managing household roles
English-speaking
Disqualifiers
Surgical menopause
Current pregnancy
Trial population
Perimenopause is associated with fatigue, sleep disturbance, vasomotor symptoms, mood changes, and cognitive difficulties. While the literature addresses symptom management, limited research examines the functional impact of perimenopause on daily occupations, work participation, and role performance. Occupational therapy (OT) emphasizes participation in meaningful activities; however, there is minimal research exploring occupational disruption during midlife hormonal transition.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Confidential Surveys
Other interventionParticipants who consent to participate will complete confidential surveys and one voluntary interview.
Treatment groups
Trial outcomes
Primary outcomes
Occupational Balance Questionnaire (OBQ-11)
An 11-item, self-report instrument developed to assess perceived occupational balance.
Secondary outcomes
Menopause-Specific Quality of Life Questionnaire (MENQOL)
A validated self-report tool designed to assess the impact of menopausal symptoms on health-related quality of life. It consists of 29 items across four domains
Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue
Measures fatigue and its effects on daily functioning, including frequency, intensity, duration, and impact on physical, cognitive, and social activities.
Other outcomes
Semi-structured interview
Participants who voluntarily agree to be contacted with high symptom severity will consent to a confidential semi-structured interview.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Russell Sage College
Lead sponsor
Binghamton University
Collaborator
This trial is not recruiting at the moment. You can still explore other options: